
What happened
Palantir's Louis Mosley said in Brussels on October 22, 2026 that NATO's Maven has no "kill switch" and that neither Palantir nor the U.S. government can stop it externally.
Why it matters
The assurance means users retain full authority to operate and manage the software, though Mosley said Europe must accept some dependence on U.S. firms like Palantir.
WHO IT HITSEuropean defense ministries and NATO commands relying on Maven now face a clearer picture of their operational control over the system, while governments weighing homegrown alternatives may see the dependence question sharpened.
Summaries like this, every morning.
Palantir's reassurance to European governments comes against the backdrop of a report that SpaceX restricted the movement speed of its Starshield military satellite communications service, which Ukraine said disrupted military missions. Mosley called that report "extremely concerning." The Starshield episode appears to have sharpened European questions about how much control a U.S. vendor or the U.S. government can exert over critical defense systems. Mosley's answer on Maven was categorical: there is no kill switch, and neither the company nor Washington can intervene externally to stop or limit it. Yet in a separate interview the same day, he changed tone, warning that Europe must accept some dependence on U.S. firms. That tension is visible in NATO's own choices: since acquiring Maven in 2025, some major members have declined to adopt it, and Germany and France are pursuing their own替代 technology. Mosley argued that even if countries like France develop alternatives, Maven would still significantly boost European defense and technology.
Pick your industry and the AI tools you use, and get news related to your work every day.
Free · 30 seconds with Google · unsubscribe anytimeWhat is AIToday? →
Ask AI anything about this article. The AI reads this article, earlier AIToday articles, and Wikipedia, and cites its sources. Q&As are published on this page for other readers too.
S&P Global reports Q3 on Oct

Tempus AI expanded its drug development collaborations with Bristol Myers Squibb and Pathos AI

Vertiv and NVIDIA presented at GTC on how they can halve AI factory deployment time

Danaher (DHR) received FDA clearance for AI-powered atrial fibrillation detection

CVS Health appointed Jack Hanlon, who previously held senior data and analytics roles at Meta and Reddit, as s…

T-Mobile US completed what Nvidia described as the first AI-RAN call on a live commercial network, unveiled at…
